Akers Biosciences Announces Its Financial Results for Third Quarter 2014
November 13, 2014 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and testing...
Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial Results
November 10, 2014 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China
October 23, 2014 08:17 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Biosciences Features on Global Broadcast & Online Media
September 16, 2014 12:45 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces...
Akers Biosciences Presenting at US Investor Conferences
September 09, 2014 13:42 ET
|
Akers Biosciences Inc.
Executive Chairman Raymond F. Akers Jr., Ph.D, to present at:
Rodman & Renshaw 16th Annual Global Investment Conference; and Aegis Capital Corporation 2014 Healthcare & Technology...
Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test
September 09, 2014 07:30 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Biosciences Reports Its Second Quarter Financial Results
August 12, 2014 07:00 ET
|
Akers Biosciences Inc.
Sales of flagship PIFA Heparin/PF4 products increasing
Conference call scheduled for 10:15 a.m. ET today
THOROFARE, N.J., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER)...
Akers Biosciences Announces Conference Call to Discuss Its Second Quarter and Six Months Financial Results
August 11, 2014 12:17 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Appoints New Vice President of International Sales and Marketing to Build International Business
August 05, 2014 02:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
July 28, 2014 02:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., July 28, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...